References
- Azzazy H, Pelsers M, Christenson R. (2006). Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clin Chem 52:19–29.
- de Groot MJ, Muijtjens AM, Simoons ML, Hermens WT, Glatz JF. (2001). Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma. Heart 85:278–85.
- de Lemos JA, Antman EM, Morrow DA, et al. (2000). Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 298:85–97.
- Glatz JF, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP,Hermens WT. (1998). Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 272:87–92.
- Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M. (2004). Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric surgery. J Thorac Cardiovasc Surg 127:1697–702.
- Hayashida N, Chihara S, Akasu K, et al. (2000). Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery. Jpn Circ 64:18–22.
- Ishii J, Nagamura Y, Nomura M, et al. (1997). Early detection of successful coronary reperfusion based on serum concentration of human heart-type cytoplasmic fatty acid-binding protein. Clin Chim Acta 262:13–27.
- Kilcullen N, Viswanathan K, Das R, et al. (2007). Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 50:2061–7.
- Kleine AH, Galtz JF, Van Nieuwenhoven FA, Van der Vusse GJ. (1992). Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116:155–62.
- Kleinfeld AM, Prothro D, Brown DL, Davis RC, Richieri GV, DeMaria A. (1996). Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol 78:1350–4.
- Meng X, Ming M, Wang E. (2006). Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. Forensic Sci Int 160:11–16.
- O’Donoghue M, de Lemos JA, Morrow DA, et al. (2006). Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 114:550–7.
- Okamoto F, Sohmiya K, Ohkaru Y, et al. (2000). Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of myocardial infarction: clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 38:231–8.
- Petzold T, Feindt P, Sunderdiek U, Boeken U, Fischer Y, Gams E. (2001). Heart-type fatty acid protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardothorac Surg 19:859–64.
- Seino Y, Ogata K, Takano T, et al. (2003). Use of a whole blood rapid, panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 115:185–90.
- Sohmiya K, Tanaka T, Tsuji R, et al. (1993). Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 25:1413–26.